Evidence map›Paper›PMID 36305698›Full record

ArticleEpilepsia open2023

Experiences from COVID-19 vaccination in patients with epilepsy.

Li Yang, Jiaxiu He, Zhi Song, Wen Zhen, Ru Chen, Cheng Zhang, Heng Yang, Ding Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epilepsia open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Li YangDepartment of Epilepsy Centre and Neurology, The Third Xiangya Hospital, Central South University, Changsha, China.ORCID 0000-0002-6610-9987
Jiaxiu HeDepartment of Epilepsy Centre and Neurology, The Third Xiangya Hospital, Central South University, Changsha, China.
Zhi SongDepartment of Epilepsy Centre and Neurology, The Third Xiangya Hospital, Central South University, Changsha, China.
Wen ZhenDepartment of Epilepsy Centre and Neurology, The Third Xiangya Hospital, Central South University, Changsha, China.
Ru ChenDepartment of Epilepsy Centre and Neurology, The Third Xiangya Hospital, Central South University, Changsha, China.
Cheng ZhangDepartment of Epilepsy Centre and Neurology, The Third Xiangya Hospital, Central South University, Changsha, China.
Heng YangDepartment of Epilepsy Centre and Neurology, The Third Xiangya Hospital, Central South University, Changsha, China.
Ding LiuDepartment of Epilepsy Centre and Neurology, The Third Xiangya Hospital, Central South University, Changsha, China.ORCID 0000-0002-5316-2762
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to investigate the safety of coronavirus disease 2019 (COVID-19) vaccination in patients with epilepsy (PWE) and their willingness to undergo vaccination.

methodsThis study was a survey the survey questionnaire, which included general, epilepsy-specific, and COVID-specific questions, was completed by patients of the outpatient clinic and hospital ward at The Third Xiangya Hospital in 2021.

resultsA total of 120 valid questionnaires were returned. Eighty-nine of 120 responders (74.2%) were not vaccinated, and 31 (25.8%) were vaccinated against COVID-19. Of the 31 vaccinated PWE, one (3.2%) had worsening of seizures and four (12.9%) had adverse reactions that were characteristic of the COVID-19 vaccine. The other 26 patients (83.9%) reported no adverse reactions, Moreover, there was no significant difference between the 18 PWE with well-controlled seizures and the 13 PWE with poorly-controlled seizures. Of the 89 unvaccinated PWE, 69.7% (62/89) were willing to receive the COVID-19 vaccine, 28.1% (25/89) were unsure, and 2.2% (2/89) declined to be vaccinated. SIGNIFICANCE: Among PWE, few adverse reactions occurred following the COVID-19 vaccination. Most PWE were willing to receive the COVID-19 vaccine. COVID-19 vaccination is safe for PWE.

Indexed as

COVID-19EpilepsyEpilepsy, GeneralizedCOVID-19 VaccinesHumansSeizuresVaccinationCOVID-19 VaccinesCOVID-19patients with epilepsy (PWE)vaccination

Identifiers

PMID36305698
PMCPMC10235549
OpenAlexW4307496387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.